RPRX

ROYALTY PHARMA PLC

RPRX·G7709Q104·US·Common Stock·Healthcare - Biotechnology-Activist

SHS CLASS A

RPRX (ROYALTY PHARMA PLC) is held by 244 institutional investors as of Q2 2026. Largest holders: MORGAN STANLEY ($2.4B), Capital International Investors ($2B), BlackRock, Inc. ($1.6B). Net institutional sentiment: Mixed.

244
Holders
(24 Elite)
$17.4B
Total Value
65% (247)
Consensus
160 buying - 87 selling
13F: Insider & Congress: Updated regularly
RPRX

Smart Money Verdict

View all
Loading verdict
Held by 244 funds
24 elite

Who's Trading

Source dates: Price Sep 21, 2026 · Insiders Aug 19, 2026 · Activists Aug 17, 2026 · Congress none

InsiderHCHite ChristopherGift 17K shAug 19, 2026
InsiderHCHite ChristopherSell $6.0MAug 18, 2026
ActivistLGLegorreta G. Pablo18.7%Aug 17, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
42.9M(-1.5%)$2.4B0.1%+103.60%
0
Increased
35.3M(+0.8%)$2B0.4%+58.39%
38
Increased
27.8M(+7.4%)$1.6B0.0%+114.06%
34
Decreased
24.5M(-2.5%)$1.4B0.1%+119.77%
0
Increased
12.3M(+12.3%)$691.8M0.0%+89.09%
35
Decreased
10.7M(-7.4%)$601.4M0.5%+104.19%
0
Decreased
10M(-38.0%)$561.6M0.5%+59.22%
0
Increased
9.5M(+18.4%)$533.6M0.1%+19.68%
37
Increased
8.1M(+2.4%)$450.6M0.0%+68.63%
32
Increased
4.8M(+6.5%)$270.6M0.0%+21.63%
33
Increased
4.7M(+23.9%)$264.6M0.0%+55.39%
37
Increased
4.3M(+13.4%)$242.2M0.4%+22.18%
42
Increased
4.3M(+13.8%)$241.4M0.1%+53.78%
35
Increased
4.2M(+12.8%)$237.3M0.0%+38.32%
35
Increased
4.1M(+18.7%)$232.7M0.0%+61.41%
36
Increased
3.8M(+13.0%)$213.1M0.0%+50.19%
35
Increased
3.7M(+20.6%)$208.8M0.1%+50.55%
36
Decreased
3.7M(-4.4%)$206.5M0.1%+85.29%
0
Increased
3.1M(+73.5%)$176.2M0.0%+37.60%
46
Increased
3.1M(+1.8%)$172.9M0.0%+85.95%
31

Showing 1-20 of 258

1 / 13
RPRXRPRXROYALTY PHARMA PLC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used